The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread

Author:

Arieti Fabiana12,Savoldi Alessia12,Rejendran Nithya Babu345,Sibani Marcella12,Tebon Maela12,Pezzani Maria Diletta67,Gorska Anna12,Wozniak Teresa M89,Tacconelli Evelina12345

Affiliation:

1. Division of Infectious Diseases , Department of Diagnostics and Public Health, , Verona 37134, Italy

2. University of Verona , Department of Diagnostics and Public Health, , Verona 37134, Italy

3. Division of Infectious Diseases , Department of Internal Medicine I, German Center for Infection Research, , Tübingen 72074, Germany

4. University of Tübingen , Department of Internal Medicine I, German Center for Infection Research, , Tübingen 72074, Germany

5. German Centre for Infection Research (DZIF), Clinical Research Unit for Healthcare Associated Infections , Tübingen 72074, Germany

6. Division of Infectious Diseases , Department of Medicine, , Verona 37134, Italy

7. Verona University Hospital , Department of Medicine, , Verona 37134, Italy

8. Menzies School of Health Research, Charles Darwin University , Darwin 8100, Northern Territory, Australia

9. Australian e-Health Research Centre CSIRO , Brisbane 4000, Qeensland Australia

Abstract

Abstract Background International travel has been recognized as a risk factor contributing to the spread of antimicrobial resistance (AMR). However, tools focused on AMR in the context of international travel and designed to guide decision-making are limited. We aimed at developing an evidence-based educational tool targeting both healthcare professionals (HCPs) and international travellers to help prevent the spread of AMR. Methods A literature review on 12 antimicrobial-resistant bacteria (ARB) listed as critical and high tiers in the WHO Pathogen Priority List covering four key areas was carried out: AMR surveillance data; epidemiological studies reporting ARB prevalence data on carriage in returning travellers; guidance documents reporting indications on screening for ARB in returning travellers and recommendations for ARB prevention for the public. The evidence, catalogued at country-level, provided the content for a series of visualizations that allow assessment of the risk of AMR acquisition through travel. Results Up to January 2021, the database includes data on: (i) AMR surveillance for 2.018.241 isolates from 86 countries; (ii) ARB prevalence of carriage from 11.679 international travellers and (iii) 15 guidance documents published by major public health agencies. The evidence allowed the development of a consultation scheme for the evaluation of risk factors, prevalence of carriage, proportion and recommendations for screening of AMR. For the public, pre-travel practical measures to minimize the risk of transmission were framed. Conclusions This easy-to-use, annually updated, freely accessible AMR travel tool (https://epi-net.eu/travel-tool/overview/), is the first of its kind to be developed. For HCPs, it can provide a valuable resource for teaching and a repository that facilitates a stepwise assessment of the risk of AMR spread and strengthen implementation of optimized infection control measures. Similarly, for travellers, the tool has the potential to raise awareness of AMR and outlines preventive measures that reduce the risk of AMR acquisition and spread.

Funder

Innovative Medicines Initiative Joint Undertaking

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3